|
Volumn 19, Issue 6, 2001, Pages 1161-1165
|
Efficacy of an angiotensin II receptor antagonist in managing hyperaldosteronism
|
Author keywords
Angiotensin II receptor antagonists; Hyperaldosteronism; Hypertension, ambulatory blood pressure recording; Irbesartan; Spironolactone
|
Indexed keywords
ALDOSTERONE;
AMLODIPINE;
ANGIOTENSIN;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CLONIDINE;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ELECTROLYTE;
ENALAPRIL;
HYDROCORTISONE;
IRBESARTAN;
METHYLDOPA;
NIFEDIPINE;
PERINDOPRIL;
PLACEBO;
POTASSIUM;
SPIRONOLACTONE;
THIAZIDE DIURETIC AGENT;
ADULT;
AGED;
ALDOSTERONE BLOOD LEVEL;
ANGIOTENSIN BLOOD LEVEL;
ARTICLE;
BLOOD PRESSURE MONITORING;
BLOOD PRESSURE REGULATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
HORMONE RESPONSE;
HUMAN;
HYDROCORTISONE BLOOD LEVEL;
HYPERALDOSTERONISM;
HYPERTENSION;
MALE;
PLASMA RENIN ACTIVITY;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
|
EID: 0035010094
PISSN: 02636352
EISSN: None
Source Type: Journal
DOI: 10.1097/00004872-200106000-00022 Document Type: Article |
Times cited : (11)
|
References (19)
|